Publications by authors named "Peilong Zhang"

Claim this Profile
V
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study.
Yi-Long Wu, Yu Yao, Jin-Ji Yang, Lin Wu, Wei Zhang, Yan Zhang, Pei-Long Zhang

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate dehydrogenase to albumin ratio as a prognostic indicator for patients with resectable non-small cell lung cancer.
Bohua Wei, Weijie Li, Kun Qian, Peilong Zhang, Yuanbo Li, Yi Zhang

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study.
Jin-Ji Yang, Yu Mu, Zhe-Hai Wang, Jian-Chun Duan, Yan Zhang, Pei-Long Zhang

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of lactate dehydrogenase to albumin ratio in first-line chemoimmunotherapy for locally advanced or metastatic non-small cell lung cancer.
Bohua Wei, Hao Cui, Kun Qian, Kejian Shi, Peilong Zhang, Yi Zhang

Transl Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical analysis of incidental discovery of pulmonary nodules with computed tomography: a retrospective cohort study.
Peilong Zhang, Bohua Wei, Gaojun Lu, Yi Zhang

J Thorac Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidental mediastinal masses detected on chest computed tomography scans during the COVID-19 pandemic.
Gaojun Lu, Peilong Zhang, Sara Ricciardi, Ruotian Wang, Chen Wang, Yi Zhang

Eur J Cardiothorac Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic and transcriptomic profiling of pulmonary nodules in synchronous multiple primary lung cancer.
Xingsheng Liu, Kun Qian, Lei Su, Xiaoru Tian, Xin Zhao, Peilong Zhang, Yi Zhang

Eur J Med Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, mass balance, and metabolism of [C]PLB1004, a selective and irreversible EGFR-TKI in humans.
Donghui Liu, Qian Li, Shu Yan, Xinyue Zhang, Weiqiang Li, Peilong Zhang

Cancer Chemother Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study.
Jin-Ji Yang, Yan Zhang, Lin Wu, Jie Hu, Zhe-Hai Wang, Wei Zhang, Pei-Long Zhang

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of systemic immune-inflammation index in the high-grade subtypes components of small-sized lung adenocarcinoma.
BoHua Wei, Yi Zhang, Kejian Shi, Xin Jin, Kun Qian, Peilong Zhang

J Cardiothorac Surg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTPRZ1-METFUsion GENe (ZM-FUGEN) trial: study protocol for a multicentric, randomized, open-label phase II/III trial.
Zhaoshi Bao, Shouwei Li, Liang Wang, Bisi Zhang, Peilong Zhang

Chin Neurosurg J· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, Deyi Zhang, Hongbin Yuan, Ling Zhang, Ruihao Zhang

Bioorg Med Chem Lett· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, Deyi Zhang, Can Jin, Ling Zhang, Ruihao Zhang

Bioorg Med Chem Lett· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Kinetics and influencing factors of dimethyl phthalate degradation in aqueous solution by ozonation].
Li Yu, Pei-Long Zhang, Jia-Cai Hou, Li-Fei Pang, Yue Li

Huan Jing Ke Xue· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and cellular effect of a novel conjugate of polyamide and phospholipid.
Yi Liu, Yulin Deng, Rong Zheng, Peilong Zhang, Hui Zhai

Chem Pharm Bull (Tokyo)· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis